Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Renuka Ramnath resigns...

    Renuka Ramnath resigns from Fortis expert panel

    Written by Ruby Khatun Khatun Published On 2018-04-26T10:14:47+05:30  |  Updated On 26 April 2018 10:14 AM IST
    Renuka Ramnath resigns from Fortis expert panel

    New Delhi: Fortis Healthcare said Renuka Ramnath, former MD, and CEO of ICICI Venture, has resigned from the expert committee set by the healthcare major to evaluate binding proposals and make final recommendations to the board.


    In a regulatory filing, Fortis Healthcare Limited (FHL) said it has received the resignation of Ramnath, wherein she excused herself from being the member of the committee due to her pre-occupation.


    "The same will be tabled before the board at the scheduled meeting on April 26, 2018, for their consideration and vacancy so caused shall be filled, by the board of directors, with a person of eminent repute," it added.


    The committee is headed by Deepak Kapoor, former chairman and CEO of Price Waterhouse Coopers, India.


    The other members of the panel included Ramnath and Lalit Bhasin, president, Society of Indian Law Firms & Managing Partner, Bhasin & Co.


    Last week, FHL had approved evaluation of only binding offers and formed an expert committee to evaluate the proposals and make a final recommendation by April 26.


    On the basis of the decision by the board, the final proposal will be put forward to the shareholders for their approval.


    Already, four entities -- KKR-backed Radiant Life Care, Malaysian major IHH Healthcare, Manipal/TPG consortium and Munjal and Burman family offices -- have given binding offers to FHL.


    Read also: Fortis Update: Investors pile up with revised Offers
    binding proposalsBurman familyDeepak Kapoorexpert panelFortisFortis HealthcareICICI ventureIHH HealthcareLalit BhasinManipalMunjalRadiant Life CareRenuka Ramnathresigns
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok